Allspring Global Investments Holdings, LLC Vertex Pharmaceuticals Inc Transaction History
Allspring Global Investments Holdings, LLC
- $59.3 Billion
- Q4 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 96,626 shares of VRTX stock, worth $44.4 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
96,626
Previous 236,326
59.11%
Holding current value
$44.4 Million
Previous $110 Million
64.6%
% of portfolio
0.07%
Previous 0.18%
Shares
13 transactions
Others Institutions Holding VRTX
# of Institutions
1,751Shares Held
227MCall Options Held
1.64MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$13 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.7 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.78 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.5 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$4.79 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $118B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...